Fundraising Fox

Antiva Biosciences

7 known investors

antivabio.com ↗

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry. The company targets an unmet clinical need where no approved therapeutic options currently exist.

BiotechFemTechHealthtechMedical Devices

Investors · 7

Adjuvant CapitalNew York
Canaan PartnersStamford
Lumira VenturesToronto, Ontario
MPM BioImpactBoston
Sofinnova VenturesMenlo Park
GaingelsreportedNew York
Osage University Partnersreported$1M – $20M

In the news